November 05, 2025

Get In Touch

Fatty Liver Index May Detect Diabetes Even When Blood Sugar And IR Levels Normal

Incidence of Diabetes and Fatty Liver Index

Incidence of Diabetes and Fatty Liver Index

Incidence of diabetes is on the rise globally. One of the underlying mechanisms of type 2 diabetes is uncontrolled metabolism of glucose. The liver plays an important role in controlling blood sugar in various pathways, including glycogenesis, glycogenolysis, glycolysis, and gluconeogenesis, and several studies have focused on the relationship between liver dysfunction and Type 2 diabetes.

The fatty liver index (FLI) can be very useful for managing fatty liver and preventing related diseases. As of now, no large-scale and long-term follow-up prospective studies have investigated the relationship between FLI and incident type 2 diabetes (T2DM) independent of baseline insulin resistance status.

Researchers have found in a new study that baseline fatty liver index could be a promising guide for the early detection of type 2 diabetes even when prior blood sugar or insulin (HOMA-IR) levels are normal. The study has been published in the journal Cardiovascular Diabetology.

Blood sugar provides energy to cells of the body and acts as fuel, driving our cells, tissues, muscles, and organs to perform their respective tasks. In some individuals, cells of the body defy the signals that insulin sends and refuse to absorb sugar from the blood, and this is called insulin resistance. When insulin resistance develops, blood sugar levels begin to soar, leading to the development of diabetes.

Type 2 diabetes (T2DM) is a significant cause of mortality and comorbidity in various cardiovascular diseases and many other types of cancer. Fatty liver disease is commonly associated with T2DM. It is necessary to diagnose fatty liver and identify disease status to prevent liver-related diseases. The fatty liver index (FLI), an easily available tool in clinical practice, can be very useful for managing fatty liver and preventing related diseases. There is not much literature to investigate the relationship between FLI and incident type 2 diabetes (T2DM) independent of baseline insulin resistance status. Hence, researchers from Korea conducted a study to evaluate the association between FLI and incident T2DM and to determine if FLI could be used as an indicator of T2DM using a large-sample, community-based Korean cohort over 12 years.

Also Read: Increased use of dairy and milk diet linked to a higher risk of stroke and angina mortality: Study

Of the 10,030 participants, 7,777 participants with 3,676 men and 4,101 women without diabetes were selected from the present study's Korean Genome and Epidemiology Study (KoGES). FLI is graded into 3 groups:

  • Low FLI with a score of < 30
  • Intermediate, FLI from 30–59
  • High, FLI ≥ 60

The hazard ratios (HRs) with 95% confidence intervals (CIs) for incident T2DM were calculated using multivariate Cox proportional hazards regression models after adjusting for potentially confounding variables.

Results

In total, 1,490 individuals (19.2%) developed T2DM during follow-up. After adjusting for potentially confounding variables, including the HOMA-IR marker, the HRs of incident T2DM for the FLI (30–59), and FLI (≥ 60) increased compared to the reference FLI (< 30). FLI was positively related to incident T2DM independent of baseline insulin resistance after adjusting for potential confounding variables.

Also Read: Cholelithiasis tied to increased risk of prostate cancer, suggests a study

Thus, the present study throws light on how high FLI precedes and significantly predicts the future development of T2DM among community-dwelling and middle-aged older Korean adults.

Further reading: Seo, IH., Lee, H.S. & Lee, YJ. Fatty liver index as a predictor for incident type 2 diabetes in community-dwelling adults: longitudinal findings over 12 years. Cardiovasc Diabetol 21, 209 (2022). https://doi.org/10.1186/s12933-022-01642-1

Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our Terms of Use, Privacy Policy, and Advertisement Policy.
For further details, please review our Full Disclaimer.

0 Comments

Post a comment

Please login to post a comment.

No comments yet. Be the first to comment!